|
1.
|
A JemalR SiegelE WardCancer statistics,
2008CA Cancer J Clin587196200810.3322/CA.2007.0010
|
|
2.
|
SH GiordanoMale breast cancer: it's time
for evidence instead of extrapolationOnkologie315055062008
|
|
3.
|
KA RosenblattDB ThomasA McTiernanBreast
cancer in men: aspects of familial aggregationJ Natl Cancer
Inst83849854199110.1093/jnci/83.12.8492061945
|
|
4.
|
F MarchalM SalouC MarchalMen with breast
cancer have same disease-specific and event-free survival as
womenAnn Surg
Oncol16972978200910.1245/s10434-009-0327-619184227
|
|
5.
|
K LynnRare male breast cancer has
similarities to female diseaseMLO Med Lab Obs423436201021213581
|
|
6.
|
L NeumayerTL SchifftnerWG HendersonBreast
cancer surgery in Veterans Affairs and selected university medical
centers: results of the patient safety in surgery studyJ Am Coll
Surg20412351241200710.1016/j.jamcollsurg.2007.03.018
|
|
7.
|
K AnanS MitsuyamaK NishiharaBreast cancer
in Japanese men: does sex affect prognosis?Breast
Cancer11180186200410.1007/BF0296829915550865
|
|
8.
|
JJ ShusterMedian follow-up in clinical
trialsJ Clin Oncol919119219911985169
|
|
9.
|
EL KaplanP MeierNonparametric estimation
from incomplete observationsJ Am Statist
Assoc53457481195810.1080/01621459.1958.10501452
|
|
10.
|
SH GiordanoDS CohenAU BuzdarBreast
carcinoma in men: a population-based
studyCancer1015157200410.1002/cncr.2031215221988
|
|
11.
|
MG JoshiAK LeeM LodaMale breast carcinoma:
an evaluation of prognostic factors contributing to a poorer
outcomeCancer77490498199610.1002/(SICI)1097-0142(19960201)77:3%3C490::AID-CNCR10%3E3.0.CO;2-%238630956
|
|
12.
|
PC WillsherIH LeachIO EllisA comparison
outcome of male breast cancer with female breast cancerAm J
Surg173185188199710.1016/S0002-9610(97)89592-X9124623
|
|
13.
|
MB El-TamerIK KomenakaA TroxelMen with
breast cancer have better disease-specific survival than womenArch
Surg13910791082200410.1001/archsurg.139.10.107915492147
|
|
14.
|
WF AndersonMD AlthuisLA BrintonSS DevesaIs
male breast cancer similar or different than female breast
cancer?Breast Cancer Res
Treat837786200410.1023/B:BREA.0000010701.08825.2d14997057
|
|
15.
|
C RudlowskiN FriedrichsA FaridiHer-2/neu
gene amplification and protein expression in primary male breast
cancerBreast Cancer Res
Treat84215223200410.1023/B:BREA.0000019953.92921.7e15026619
|
|
16.
|
DG TiezziJM AndradeA Ribeiro-SilvaHER-2,
p53, p21 and hormonal receptors proteins expression as predictive
factors of response and prognosis in locally advanced breast cancer
treated with neoadjuvant docetaxel plus epirubicin combinationBMC
Cancer736200710.1186/1471-2407-7-36
|
|
17.
|
JM BentelSN BirrellMA PicheringAndrogen
receptor agonist activity of the synthetic progestin,
medroxyprogesterone acetate, in human breast cancer cellsMol Cell
Endocrinol1541120199910.1016/S0303-7207(99)00109-4
|
|
18.
|
A AuvinenRE CurtisE RonRisk of subsequent
cancer following breast cancer in menJ Natl Cancer
Inst9413301332200210.1093/jnci/94.17.133012208898
|
|
19.
|
C DongK HemminkiSecond primary breast
cancer in menBreast Cancer Res
Treat66171172200110.1023/A:101063942920711437104
|
|
20.
|
NC HodgsonJH ButtonD FranceschiMale breast
cancer: is the incidence increasing?Ann Surg
Oncol11751755200410.1245/ASO.2004.01.00115289238
|
|
21.
|
K HemminkiG SceloP BoffettaSencond primary
malignancies in patients with male breast cancerBr J
Cancer9212881292200510.1038/sj.bjc.660250515798766
|
|
22.
|
SB LeibowitzJE GarberEA FoxMale patients
with diagnoses of both breast cancer and prostate cancerBreast
J9208212200310.1046/j.1524-4741.2003.09312.x12752629
|
|
23.
|
S Satram-HoangA ZiogasH Anton-CulverRisk
of second primary cancer in men with breast cancerBreast Cancer
Res9R10200710.1186/bcr164317254323
|
|
24.
|
National Comprehensive Cancer NetworkNCCN
practice guidelines in oncology 2009Available from: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp.
Accessed 30 May, 2010
|
|
25.
|
SH GiordanoAU BuzdarGN HortobagyiBreast
cancer in menAnn Intern
Med137678687200210.7326/0003-4819-137-8-200210150-0001312379069
|
|
26.
|
SH GiordanoGH PerkinsK BroglioAdjuvant
systemic therapy for male breast
carcinomaCancer10423592364200510.1002/cncr.2152616270318
|
|
27.
|
A AgrawalAA AyantundeR RampaulJF
RobertsonMale breast cancer: a review of clinical managementBreast
Cancer Res Treat1031121200710.1007/s10549-006-9356-z
|
|
28.
|
Z NahlehS GirniusMale breast cancer: a
gender issueNat Clin Pract Oncol3428437200610.1038/ncponc0564
|
|
29.
|
IS FentimanA FourquetGN HortobagyiMale
breast cancerLancet367595604200610.1016/S0140-6736(06)68226-3
|
|
30.
|
A MariottoEJ FeuerLC HarlanTrends in use
of adjuvant multi-agent chemotherapy and tamoxifen for breast
cancer in the United States: 1975–1999J Natl Cancer
Inst94162616342003
|
|
31.
|
G RibeiroR SwindellAdjuvant tamoxifen for
male breast cancer (MBC)Br J
Cancer65252254199210.1038/bjc.1992.501739625
|
|
32.
|
TF AnelliA AnelliKN TranTamoxifen
administration is associated with a high rate of treatment-limiting
symptoms in male breast cancer
patientsCancer747477199410.1002/1097-0142(19940701)74:1%3C74::AID-CNCR2820740113%3E3.0.CO;2-%238004585
|
